Biomimetic nano-in-gel vaccine platform with spatiotemporal co-delivery capacity for DC maturation against immunosuppressive tumors
Therapeutic tumor vaccinations are promising for cancer immunotherapy. However, challenges like inadequate antigen encapsulation, weak immune activation, and an immunosuppressive tumor microenvironment limit their efficacy. To overcome these, an injectable Nano-in-Gel vaccine composed of porcine lung-derived extracellu...